A Predictive Score for the Ischemic Etiology of a Transient Diplopia (VASCO-DIP)
Condition(s) studied
Investigational drug(s) / intervention(s)
Clinical, ophthalmological and neurological evaluation: Clinical : questionnaire about the symptoms and about the vascular risk factors Imagery :Cerebral MRI, MRI angiography of the supra-aortic trunks, ECG, Holter, transthoracic echocardiography, Biology : blood count, erythrocytes sedimentation rate, C reactive protein Ophthalomogy : visual field, optical coherence tomography, retinography
Study summary
The transient diplopias (TD) is defined by a short diplopia. Their etiology may be ophthalmological, neurological non-ischemic or of ischemic origin.
The difficulty is to recognize an ischemic mechanism which imposes emergency cares.
A clinical score could help the clinician to recognize the etiology of the TD .
Eligibility
Primary outcome measure(s)
- Etiology, ischemic or not, of the initial transient diplopia — 3 months
Questionnaire about the symptoms and about the vascular risk factors, cerebral MRI, MRI angiography of the supra-aortic trunks, ECG, Holter, transthoracic echocardiography, blood count, erythrocytes sedimentation rate, C reactive protein, visual field, optical coherence tomography, retinography and a new evaluation after 3 months.
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Hôpital Bichat | Paris | France | Recruiting |
| Fondation Ophtalmologique Adolphe de Rothschild | Paris | Île-de-France Region | Recruiting |
More Fondation Ophtalmologique Adolphe de Rothschild trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT02576925 on ClinicalTrials.gov ↗ ← All trials in France